Cita APA

Marcé, S., García, O., Estrada, N., Vélez, P., Cortes, M., Cabezón, M., & Xicoy, B. (2021). Impact of BCR-ABL1 Transcript Type on Response, Treatment-Free Remission Rate and Survival in Chronic Myeloid Leukemia Patients Treated with Imatinib.

Citación estilo Chicago

Marcé, Silvia, Olga García, Natalia Estrada, Patricia Vélez, Montse Cortes, Marta Cabezón, y Blanca Xicoy. Impact of BCR-ABL1 Transcript Type On Response, Treatment-Free Remission Rate and Survival in Chronic Myeloid Leukemia Patients Treated With Imatinib. 2021.

Cita MLA

Marcé, Silvia, et al. Impact of BCR-ABL1 Transcript Type On Response, Treatment-Free Remission Rate and Survival in Chronic Myeloid Leukemia Patients Treated With Imatinib. 2021.